Author | Laura Newman, MA

Articles

FDA Advisory Panel Recommends Approval of Tysabri

April 05, 2006

multiple sclerosis, MS, Tysabri, natalizumab, progressive multifocal leukoencephalopathy, PML

Stroke Guidelines Address Broader Issues

March 31, 2006

The most comprehensive evidence-based recommendations for preventing a second stroke have been released by the American Heart Association and the American Stroke Association's Stroke Council.1 In contrast with previous clinical practice guidelines, the new guidelines tie transient ischemic attack (TIA) with stroke, said Ralph Sacco, MD, chair of the American Stroke Association's Secondary Stroke Prevention Guidelines Committee.

Medicare Part D Prompts Formulary Concerns

March 31, 2006

When Medicare enrollees became entitled to the first-ever outpatient prescription drug benefit in January, the program was introduced with great fanfare and with the mission of Medicare Part D programs to make drugs more affordable for the elderly and disabled. The Medicare drug benefit issue, however, has been mired in controversy since Congress took it up years ago.

What's New in the Revised MS Diagnostic Criteria

January 01, 2006

Multiple sclerosis, McDonald Diagnostic Criteria

Panelists Call for Broader Approach to Caring for Parkinson Patients

November 01, 2005

Parkinson disease, Disease management

Cancer Pain: What's a Neurologist's Role?

August 01, 2005

cancerpain,neuro-oncology

Mental Notes newsworthy and useful

August 01, 2005

"Chemobrain," a term coined by patients in breast cancer support groups to describe cognitive impairment associated with chemotherapy, is becoming a subject of research.

Clinical Trials Appear Headed for More OpennessNeurology Newsfeature

July 01, 2005

All clinical trial sponsors will be required to register all publicly and privately sponsored clinical trials with the existing government clinical trials registry, www.clinicaltrials.gov, before the first patient is enrolled in the trial.